Smart-Money SignalNeutral · 45/100— Insiders are net sellers over 90 days (-$2.6M, 5 sales vs 10 buys)
Net Income-$159.0M
EPS$-2.15
Market Cap$5.8B
Price Performance
Historical data including institutional events
Company Profile
R
Robert Barrow
CEO & Executive Director
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
